CIRCULATING DONOR-DERIVED CELL FREE DNA AS A NONINVASIVE BIOMARKER FOR ALLOGRAFT REJECTION

$200,000FY2017Department of the ArmyDOD

Brigham & Womens Hospital Inc

Investigators